A question appeared on the Facebook Haematology Interest Group “Is there any lab still using The Lee and White Test for Coagulation Time?”
It rang a vague bell… I had to look it up. Whole blood clotting time… Does anyone still do it? I can remember people laughing at it nearly forty years ago.
In the subsequent discussion it turned out that some people still do perform that test.
I wonder why…
Someone posted a flippant comment on the Facebook Haematology Interest Group about “squashed duck” cells. One of the more normal people on that group took umbrage with the “non-standardised” morphological comments being used.
But after all the sighs and “get a life” comments had been made, this article emerged from the dust.
It makes for dry reading, but some sort of consistency in the reporting of blood film morphology is really needed.
The nice people at Transfusion News sent out their update today...
|Perioperative RBC Transfusions Linked to Increased Risk of Blood Clots|
|June 20, 2018|
Venous thromboembolism (VTE) is associated with 5-10% of all hospital deaths, or about 100,000 to 200,000 deaths each year in the United States. However, many of these deaths may be preventable. In order to gain a better understanding of the association between VTE and RBC transfusions, researchers used data gathered [Read More]
|Patient Blood Management: What Are You Missing? with Aryeh Shander|
|June 25, 2018 | BBGuy Podcast|
Modified transfusion thresholds? Got 'em! "Why give 2 when 1 will do?" Sure. But many patients are in trouble even before they arrive! Dr. Shander explains why preoperative anemia is a HUGE issue. [Listen Now]
Labels: Transfusion News email
The British Society of Haematology sent out an email telling me of an article outlining a possible increase in lymphoma risk for people taking Janus kinase (JAK) inhibitors to treat myelofibrosis.
Something to bear in mind when looking down the microscope at all those already odd-looking cells…
The nice people at Lablogatory sent this article today – two apparently dissimilar cases, but both with a common factor – extra-medullary haemopoesis.
I must admit that isn’t something to which I’ve given a lot of thought for some time.
This is why we do CPD…